Cabot (NYSE:CBT) Stock Rating Cut to "Hold" at Wall Street Zen

Key Points

• Wall Street Zen downgraded Cabot from “Buy” to “Hold.” The broader analyst consensus is also “Hold,” with two Buy ratings, four Holds, one Sell, and an average price target of $89.
• Cabot reported quarterly EPS of $1.67, slightly ahead of estimates, while revenue reached $982 million, up 6.4% year over year. Management guided to fiscal 2026 EPS of $6.15–$6.45.
• The stock opened at $77.14, below its 50-day and 200-day moving averages. CEO Sean Keohane sold 134,895 shares for approximately $11.5 million, while institutional investors own 93.18% of the company.

Cabot (NYSE:CBT - Get Free Report) was downgraded by analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a report released on Saturday, Wall Street Zen reports.

Other equities research analysts have also recently issued reports about the stock. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Cabot in a research report on Friday, August 21st. UBS Group lowered their target price on Cabot from $97.00 to $92.00 and set a "neutral" rating for the company in a report on Wednesday, August 5th. Mizuho lifted their price target on Cabot from $80.00 to $90.00 and gave the company a "neutral" rating in a research note on Thursday, June 25th. Truist Financial set a $100.00 price target on Cabot in a report on Wednesday, August 5th. Finally, JPMorgan Chase & Co. upped their price objective on Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a research report on Friday, August 7th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Cabot currently has an average rating of "Hold" and an average price target of $89.00.

Cabot Price Performance

NYSE CBT opened at $77.14 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $3.98 billion, a PE ratio of 21.73, a price-to-earnings-growth ratio of 8.99 and a beta of 0.83. Cabot has a 12-month low of $58.33 and a 12-month high of $94.53. The company has a 50 day moving average price of $82.83 and a two-hundred day moving average price of $82.12.

Cabot (NYSE:CBT - Get Free Report) last issued its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.66 by $0.01. The business had revenue of $982.00 million during the quarter, compared to analysts' expectations of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.Cabot's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities analysts predict that Cabot will post 6.35 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Sean Keohane sold 134,895 shares of the company's stock in a transaction on Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the sale, the chief executive officer directly owned 404,134 shares of the company's stock, valued at approximately $34,351,390. This represents a 25.03% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders sold 229,597 shares of company stock worth $19,646,746 in the last ninety days. 3.08% of the stock is owned by company insiders.

Institutional Investors Weigh In On Cabot

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. purchased a new stake in Cabot in the 2nd quarter valued at $33,000. Caitong International Asset Management Co. Ltd lifted its position in shares of Cabot by 76.8% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 944 shares of the specialty chemicals company's stock valued at $63,000 after purchasing an additional 410 shares in the last quarter. Global Retirement Partners LLC bought a new stake in Cabot in the 2nd quarter worth about $88,000. Rockefeller Capital Management L.P. increased its stake in Cabot by 115.3% in the 4th quarter. Rockefeller Capital Management L.P. now owns 1,152 shares of the specialty chemicals company's stock valued at $76,000 after buying an additional 617 shares during the last quarter. Finally, Allworth Financial LP bought a new stake in Cabot during the second quarter worth $145,000. 93.18% of the stock is owned by institutional investors.

Cabot Company Profile

Cabot Corporation NYSE: CBT is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company develops and manufactures materials used by industrial and consumer-product manufacturers worldwide.

Cabot's products include reinforcing carbon blacks used in tires, automotive components, and other rubber products; specialty carbon blacks used in coatings, plastics, inks, and batteries; and fumed silica used in adhesives, sealants, coatings, and personal-care applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.